---- Click on the presentation title to view the full abstract ----
| 11:45 | Comparisons of choroidal blood flow velocity between initial-onset acute uveitis associated with Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy | | ABU EL-ASRAR A, ALBLOUSHI A, ABOUAMMOH M, ALZUBAIDI A, GIKANDI P, AL FARAN A, AL-KHARASHI A, AL-DAHMASH S |
| 11:52 | Therapeutic Failure in Acanthamoeba Keratitis. A Retrospective Observational Study in a Referral Center in Argentina | | RODRIGUEZ S, PRINI D, SEGRETIN E, GARCIA M, M |
| 11:59 | Oral Doxycycline Therapy for Ocular Syphilis | | BAO Y, HWANG J, LONG C, DAVAR K, KAPADIA N, SPELLBERG B, WONG B, RAO N, TOY B |
| 12:06 | Ocular leprosy: socioeconomic aspects, clinico-surgical features and outcomes in the last decade | | JADHAV V S, KELGAONKAR A N, BASU S |
| 12:13 | Label-Free Imaging of Inflammation at the Level of Single Cells in the Living Human Eye | | ERRERA MH, RUI Y, MIN Z, SNYDER VC, ROSSI EA |
| 12:20 | Ophthalmic Involvement in Systemic Erythematosus Lupus and Its Association with IFN-α Gene Expression | | TEIXEIRA COSTA R, FRAGOSO T, GUARANA W, SANDRIN-GARCIA P, JUNIOR B |
| 12:27 | Use of MRI Screening Prior to Prescribing Adalimumab in Non-Infectious Uveitis (NIU) | | OZA R, BALASUBRAMANIAM B, ELSHEIKH S, SKEW H, AGOROGIANNIS G, PATIL A |
| 12:34 | Phase 2 Trial Results of ILYX-002, a Topically Administered Novel Immune Modulator for Inflammatory and Autoimmune Dry Eye Disease | | JEFFORDS E, NEWMAN E, HEMMATI H |
| | 12:41 | Closing Remarks | |
| | 12:45 | End of Session | |